Immtech Pharmaceuticals

From SourceWatch
Jump to navigation Jump to search

Immtech "has an exclusive worldwide license to develop and commercialize patented compounds derived from a proprietary medicinal platform." [1]


Accessed March 2008: [2]

  • Eric L. Sorkin - Chairman and Chief Executive Officer
  • Cecilia Chan - Executive Director and Board Member
  • David Fleet - Principal, David Fleet Pharmaceutical Industry Consultancy Services, Non-Executive Director, OnMedica Group Ltd. ,Director, IatRx Pharma Ltd.
  • Judy Lau - Chairperson, Convergent Business Group, Hong Kong, PRC
  • Levi Hong Kaye Lee - Queen Mary Hospital, Hong Kong, PRC
  • Donald F. Sinex - Board Director, Devonwood, Inc.


  • Dorothy S. Zinberg - Center for Science and International Affairs Kennedy School of Government, Harvard University



Resources and articles

Related Sourcewatch articles


  1. Home, Immtech Pharmaceuticals, accessed March 19, 2008.
  2. Directors, Immtech Pharmaceuticals, accessed March 19, 2008.